Fingerprint
Dive into the research topics of 'Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder
S. J. Pittock, A. Berthele, K. Fujihara, H. J. Kim, M. Levy, J. Palace, I. Nakashima, M. Terzi, N. Totolyan, S. Viswanathan, K. C. Wang, A. Pace, K. P. Fujita, R. Armstrong, D. M. Wingerchuk
- Mayo Clinic
- Tohoku University Graduate School of Medicine
- Fukushima Medical University
- Southern TOHOKU Research Institute for Neuroscience (STRINS)
- National Cancer Center, Gyeonggi
- Johns Hopkins University
- Massachusetts General Hospital
- John Radcliffe Hospital
- Tohoku Medical and Pharmaceutical University
- Ondokuz Mayis University
- St. Petersburg State Medical Pavlov University
- Hospital Kuala Lumpur
- National Yang-Ming University Taiwan
- Alexion Pharmaceuticals, Inc.
- Mayo Clinic Scottsdale-Phoenix, Arizona
Research output: Contribution to journal › Article › peer-review
604
Scopus
citations